infection; 'e' antigen has usually disappeared by two months and antibody to it mayor may not develop. There are limited observations on the development of anti-Hll, and in particular the numbers of patients in whom it appears. Methods of determining 'e' antigen and 'e' antibody are at present insensitive and not generally available. There is a need for a commercially produced sensitive kit for their detection.
Viral particles of hepatitis A appear in the faeces in the late incubation stage and disappear within a day or two of the development of jaundice. This makes plain the lack of infectivity of patients with type A hepatitis once they become jaundiced. It is common clinical experience that such patients may be nursed in a general medical ward and cross-infection to other patients and staff is most unusual. Procedures are now available, alas not generally, for detection of antibody to hepatitis A virus and this allows specific diagnosis of this type (Moritsugu et al. 1976 ). Non-A, non-B hepatitis can only be diagnosed by exclusion of type A, type B and other viruses. It can be transmitted by blood (Meyers et al. 1977 , Hoofnagle et al. 1977 . Clinically, it resembles type A infection and tends to affect women of 35 years or older .
TheFulminant Case
This is a rare complication of viral hepatitis, type A, type B and non-A, non-B. The prognosis is very bad, survival being in the order of 20~~of those reaching deep coma. It must therefore be recognized in the early stages ( Figure 1) . Clinical indications include a change in personality and young people may show aggressive behaviour and episodes of mania. If such changes develop; the grade of coma should be noted daily or even twice daily and recorded. Fetor hepatis may develop on the breath, vomiting is persistent and pyrexia sustained. Flapping lesion of the outstretched hands may be seen but can be transient. Jaundice deepens rapidly, although in the particularly fulminant case, death may ensue before icterus has had time to develop. The liver shrinks; the lower margin of the liver should be estimated daily by percussion and marked on the skin of the abdomen (Figure 1 The best laboratory test of severity is the prothrombin time which remains greatly prolonged in spite of intramuscular vitamin K therapy. The serum aspartate transaminase level is not a good indication of severity for it may fall, even though the clinical condition is worsening. Hypoglycaemia and a low blood urea level should be noted. The mean frequency of the electroencephalogram slows.
Death ensues a variable period after the onset, from cardiac or respiratory failure, cerebral oedema, septicaemia, renal failure, hypoglycaemia or pancreatitis or a combination of these complications.
Chronic Hepatitis This has been well described following acute type B hepatitis. In any epidemic about 10% of sufferers do not clear HBsAg from the blood within six months. Disappearance of the hepatitis B antigen after this time is extremely rare. Such carrier patients may have normal liver function and liver biopsy can also be normal. Alternatively, they develop a chronic hepatitis of varying severity, progressing in some instances to cirrhosis and to primary liver cancer (Dudley et al. 1972) .
Acute type A hepatitis probably does not proceed to chronic hepatitis. The antigen is only transiently present in the stool. In the United States 60-70% of adults have antibody to it. Follow ups of epidemics of acute type A hepatitis, both large and small, have failed to reveal the development of a chronic or carrier state.
Non-A, non-B hepatitis can be associated with a carrier hepatitis and chronic hepatitis has been described (Hoofnagle et al. 1977) .
